{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:55:12Z","timestamp":1793066112566,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Type C hepatitis B-related acute-on-chronic liver failure (HBV-ACLF), which is based on decompensated cirrhosis, has different laboratory tests, precipitating events, organ failure and clinical outcomes. The predictors of prognosis for type C HBV-ACLF patients are different from those for other subgroups. This study aimed to construct a novel, short-term prognostic score that applied serological indicators of hepatic regeneration and noninvasive assessment of liver fibrosis to predict outcomes in patients with type C HBV-ACLF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Patients with type C HBV-ACLF were observed for 90 days. Demographic information, clinical examination, and laboratory test results of the enrolled patients were collected. Univariate and multivariate logistic regression were performed to identify independent prognostic factors and develop a novel prognostic scoring system. A receiver operating characteristic (ROC) curve was used to analyse the performance of the model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 224 patients with type C HBV-ACLF were finally included. The overall survival rate within 90 days was 47.77%. Age, total bilirubin (TBil), international normalized ratio (INR), alpha-fetoprotein (AFP), white blood cell (WBC), serum sodium (Na), and aspartate aminotransferase\/platelet ratio index (APRI) were found to be independent prognostic factors. According to the results of the logistic regression analysis, a new prognostic model (named the A3Twin score) was established. The area under the curve (AUC) of the receiver operating characteristic curve (ROC) was 0.851 [95% CI (0.801-0.901)], the sensitivity was 78.8%, and the specificity was 71.8%, which were significantly higher than those of the MELD, IMELD, MELD-Na, TACIA and COSSH\u2010ACLF II scores (all P &lt; 0.001). Patients with lower A3Twin scores (&lt;-9.07) survived longer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A new prognostic scoring system for patients with type C HBV-ACLF based on seven routine indices was established in our study and can accurately predict short-term mortality and might be used to guide clinical management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-024-03276-x","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:03:50Z","timestamp":1717506230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Alpha-fetoprotein and APRI as predictive markers for patients with Type C hepatitis B-related acute-on-chronic liver failure: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Chunyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"3276_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u201390. https:\/\/doi.org\/10.1007\/s12072-019-09946-3.","journal-title":"Hepatol Int"},{"key":"3276_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00508-015-0707-9","volume":"127","author":"I Mikolasevic","year":"2015","unstructured":"Mikolasevic I, Milic S, Radic M, et al. Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF). Wien Klin Wochenschr. 2015;127:283\u20139. https:\/\/doi.org\/10.1007\/s00508-015-0707-9.","journal-title":"Wien Klin Wochenschr"},{"key":"3276_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3760\/cma.j.cn121430-20210705-01006","volume":"34","author":"Y Yan","year":"2022","unstructured":"Yan Y, Lyu C, Zhou X, et al. The predictive value of liver failure-related etiology for clinical outcomes. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022;34:172\u20137. https:\/\/doi.org\/10.3760\/cma.j.cn121430-20210705-01006.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"Suppl 1","key":"3276_CR4","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jhep.2020.11.047","volume":"75","author":"R Moreau","year":"2021","unstructured":"Moreau R, Gao B, Papp M, et al. Acute-on-chronic liver failure: A distinct clinical syndrome. J Hepatol. 2021;75(Suppl 1):S27\u201335. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.047.","journal-title":"J Hepatol"},{"key":"3276_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","volume":"147","author":"R Jalan","year":"2014","unstructured":"Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an Improved Definition of Acute-on-Chronic Liver Failure. Gastroenterology. 2014;147:4\u201310. https:\/\/doi.org\/10.1053\/j.gastro.2014.05.005.","journal-title":"Gastroenterology"},{"key":"3276_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D'Amico","year":"2018","unstructured":"D\u2019Amico G, Morabito A, D\u2019Amico M, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563\u201376. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020.","journal-title":"J Hepatol"},{"key":"3276_CR7","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","volume":"75","author":"C Engelmann","year":"2021","unstructured":"Engelmann C, Cl\u00e0ria J, Szabo G, et al. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75:S49\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.002.","journal-title":"J Hepatol"},{"key":"3276_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jgh.15113","volume":"36","author":"X Tang","year":"2021","unstructured":"Tang X, Qi T, Li B, et al. Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization. J Gastroenterol Hepatol. 2021;36:208\u201316. https:\/\/doi.org\/10.1111\/jgh.15113.","journal-title":"J Gastroenterol Hepatol"},{"key":"3276_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464\u201370. https:\/\/doi.org\/10.1053\/jhep.2001.22172.","journal-title":"Hepatology"},{"key":"3276_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.012.","journal-title":"J Hepatol"},{"key":"3276_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12072-017-9816-z","volume":"11","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Jindal A, Maiwall R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11:461\u201371. https:\/\/doi.org\/10.1007\/s12072-017-9816-z.","journal-title":"Hepatol Int"},{"key":"3276_CR12","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","volume":"67","author":"T Wu","year":"2018","unstructured":"Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67:2181\u201391. https:\/\/doi.org\/10.1136\/gutjnl-2017-314641.","journal-title":"Gut"},{"key":"3276_CR13","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","volume":"75","author":"J Li","year":"2021","unstructured":"Li J, Liang X, You S, et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol. 2021;75:1104\u201315. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.026.","journal-title":"J Hepatol"},{"key":"3276_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/apt.14927","volume":"48","author":"D Wu","year":"2018","unstructured":"Wu D, Sun Z, Liu X, et al. HINT: a novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Aliment Pharmacol Ther. 2018;48:750\u201360. https:\/\/doi.org\/10.1111\/apt.14927.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3276_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3760\/cma.j.issn.1000-6680.2019.01.001","volume":"27","author":"Liver Failure and Artificial Liver Group CSoID, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association","year":"2019","unstructured":"Liver Failure and Artificial Liver Group CSoID, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Chin J Hepatol. 2019;27(1):18\u201326. https:\/\/doi.org\/10.3760\/cma.j.issn.1000-6680.2019.01.001.","journal-title":"Chin J Hepatol"},{"key":"3276_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797\u2013805. https:\/\/doi.org\/10.1002\/hep.21563.","journal-title":"Hepatology"},{"key":"3276_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018\u201326. https:\/\/doi.org\/10.1056\/NEJMoa0801209.","journal-title":"N Engl J Med"},{"key":"3276_CR18","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/lt.21197","volume":"13","author":"A Luca","year":"2007","unstructured":"Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl. 2007;13:1174\u201380. https:\/\/doi.org\/10.1002\/lt.21197.","journal-title":"Liver Transpl"},{"key":"3276_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5062873","volume":"2020","author":"X Wang","year":"2020","unstructured":"Wang X, Sun M, Yang X, et al. Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. BioMed Res Int. 2020;2020:1\u20137. https:\/\/doi.org\/10.1155\/2020\/5062873.","journal-title":"BioMed Res Int"},{"key":"3276_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/jgh.12787","volume":"30","author":"Y Shi","year":"2015","unstructured":"Shi Y, Zheng MH, Yang Y, et al. Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation. J Gastroenterol Hepatol. 2015;30:712\u20138. https:\/\/doi.org\/10.1111\/jgh.12787.","journal-title":"J Gastroenterol Hepatol"},{"key":"3276_CR21","doi-asserted-by":"publisher","first-page":"101548","DOI":"10.1016\/j.clinre.2020.09.009","volume":"45","author":"X Mu","year":"2021","unstructured":"Mu X, Tong J, Xu X, et al. World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol. 2021;45:101548. https:\/\/doi.org\/10.1016\/j.clinre.2020.09.009.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3276_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MCC.0b013e328344b42d","volume":"17","author":"JC Olson","year":"2011","unstructured":"Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care. 2011;17:165\u20139. https:\/\/doi.org\/10.1097\/MCC.0b013e328344b42d.","journal-title":"Curr Opin Crit Care"},{"key":"3276_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/17474124.2018.1426459","volume":"12","author":"RH Zhao","year":"2018","unstructured":"Zhao RH, Shi Y, Zhao H, et al. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol. 2018;12:341\u201350. https:\/\/doi.org\/10.1080\/17474124.2018.1426459.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3276_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s005350200111","volume":"37","author":"Y Takikawa","year":"2002","unstructured":"Takikawa Y, Suzuki K. Is AFP a new reliable marker of liver regeneration in acute hepatic failure? J Gastroenterol. 2002;37:681\u20132. https:\/\/doi.org\/10.1007\/s005350200111.","journal-title":"J Gastroenterol"},{"issue":"8","key":"3276_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s005350200111","volume":"37","author":"SSCK Yang","year":"2002","unstructured":"Yang SSCK, Lai Y. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2002;37(8):626\u201332. https:\/\/doi.org\/10.1007\/s005350200111.","journal-title":"J Gastroenterol Hepatol"},{"key":"3276_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","volume":"72","author":"X Xiang","year":"2020","unstructured":"Xiang X, Feng D, Hwang S, et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020;72:736\u201345. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.013.","journal-title":"J Hepatol"},{"key":"3276_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SLA.0b013e318211caf8","volume":"253","author":"R Matsuo","year":"2011","unstructured":"Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg. 2011;253:759\u201363. https:\/\/doi.org\/10.1097\/SLA.0b013e318211caf8.","journal-title":"Ann Surg"},{"key":"3276_CR28","doi-asserted-by":"publisher","first-page":"101482","DOI":"10.1016\/j.clinre.2020.06.008","volume":"45","author":"X Xu","year":"2021","unstructured":"Xu X, Hou Z, Xu Y, et al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol. 2021;45:101482. https:\/\/doi.org\/10.1016\/j.clinre.2020.06.008.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3276_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12876-022-02239-4","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Xu W, Li X, et al. Long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure: a retrospective study. BMC Gastroenterol. 2022;22:162. https:\/\/doi.org\/10.1186\/s12876-022-02239-4.","journal-title":"BMC Gastroenterol"},{"key":"3276_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/2050640614527084","volume":"2","author":"V Verma","year":"2014","unstructured":"Verma V, Sarin SK, Sharma P, et al. Correlation of aspartate aminotransferase\/platelet ratio index with hepatic venous pressure gradient in cirrhosis. United European Gastroenterol J. 2014;2:226\u201331. https:\/\/doi.org\/10.1177\/2050640614527084.","journal-title":"United European Gastroenterol J"},{"key":"3276_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12072-020-10106-1","volume":"15","author":"F Yang","year":"2021","unstructured":"Yang F, Liu Y, Zeng B, et al. Noninvasive assessment of liver fibrosis for predicting acute-on-chronic liver failure in patients with chronic hepatitis B. Hepatol Int. 2021;15:593\u2013601. https:\/\/doi.org\/10.1007\/s12072-020-10106-1.","journal-title":"Hepatol Int"},{"key":"3276_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/jgh.12779","volume":"30","author":"GL Wong","year":"2015","unstructured":"Wong GL, Chan HL, Yu Z, et al. Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2015;30:582\u201390. https:\/\/doi.org\/10.1111\/jgh.12779.","journal-title":"J Gastroenterol Hepatol"},{"key":"3276_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.clinre.2019.07.011","volume":"44","author":"M Allaire","year":"2020","unstructured":"Allaire M, Gilgenkrantz H. The aged liver: Beyond cellular senescence. Clin Res Hepatol Gastroenterol. 2020;44:6\u201311. https:\/\/doi.org\/10.1016\/j.clinre.2019.07.011.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3276_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/liv.13504","volume":"38","author":"W Wu","year":"2018","unstructured":"Wu W, Yan H, Zhao H, et al. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: Differentiate it from No-ACLF. Liver Int. 2018;38:248\u201357. https:\/\/doi.org\/10.1111\/liv.13504.","journal-title":"Liver Int"},{"key":"3276_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1159\/000375356","volume":"33","author":"R Moreau","year":"2015","unstructured":"Moreau R. Role of Infections in Acute-on-Chronic Liver Failure. Dig Dis. 2015;33:577\u201381. https:\/\/doi.org\/10.1159\/000375356.","journal-title":"Dig Dis"},{"key":"3276_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/liv.13568","volume":"38","author":"MM Mucke","year":"2018","unstructured":"Mucke MM, Rumyantseva T, Mucke VT, et al. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality. Liver Int. 2018;38:645\u201353. https:\/\/doi.org\/10.1111\/liv.13568.","journal-title":"Liver Int"},{"key":"3276_CR37","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.14309\/ajg.0000000000000786","volume":"115","author":"JJ Alukal","year":"2020","unstructured":"Alukal JJ, John S, Thuluvath PJ. Hyponatremia in Cirrhosis: An Update. Am J Gastroenterol. 2020;115:1775\u201385. https:\/\/doi.org\/10.14309\/ajg.0000000000000786.","journal-title":"Am J Gastroenterol"},{"key":"3276_CR38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/lt.20329","volume":"11","author":"AE Ruf","year":"2005","unstructured":"Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005;11:336\u201343. https:\/\/doi.org\/10.1002\/lt.20329.","journal-title":"Liver Transpl"},{"key":"3276_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.dld.2019.08.013","volume":"52","author":"G Pereira","year":"2020","unstructured":"Pereira G, Baldin C, Piedade J, et al. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Dig Liver Dis. 2020;52:91\u20137. https:\/\/doi.org\/10.1016\/j.dld.2019.08.013.","journal-title":"Dig Liver Dis"},{"key":"3276_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12072-021-10282-8","volume":"16","author":"X Mei","year":"2022","unstructured":"Mei X, Li H, Deng G, et al. Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China. Hepatol Int. 2022;16:183\u201394. https:\/\/doi.org\/10.1007\/s12072-021-10282-8.","journal-title":"Hepatol Int"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03276-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03276-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03276-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:05:38Z","timestamp":1717506338000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03276-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3276"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03276-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the principles of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of the General Hospital of Western Theater Command (No: 2020ky031). All study participants provided oral informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}